Table 1.
Demographic and baseline clinical characteristics of HF patients prior to HeartMate II, Jarvik and HeartWare implantation
| Characteristics | Pre-implant HF patients (n=26) |
||
|---|---|---|---|
| HeartMate II (n=8) | Jarvik (n=9) | HeartWare (n=9) | |
| Demography | |||
| Age in years, median (IQR) | 62 (57–76) | 62 (23–70) | 62 (25–71) |
| Sex, n(% male) | 6 (75.0%) | 9 (100%) | 6 (66.7%) |
| Race | |||
| Caucasian white, n(%) | 3 (37.5%) | 4 (44.4%) | 3 (33.3%) |
| Black, n(%) | 5 (62.5%) | 4 (44.4%) | 5 (55.6%) |
| Hispanic or Latino, n(%) | - | 1 (11.1%) | 1 (11.1%) |
| Height in meter, median (IQR) | 1.7 (1.6–1.9) | 1.8 (1.7–1.9) | 1.8 (1.7–1.9) |
| Weight in kilograms, median (IQR) | 84.0 (48.1–127.9) | 89.6 (76.6–119.4) | 78.9 (53.0–109.1) |
| Body mass index (kg/m2), median (IQR) | 27.7 (17.0–38.2) | 29.2 (24.2–39.0) | 24.4 (19.5–32.2) |
| Body surface area (m2), median (IQR) | 1.9 (1.5–2.5) | 2.2 (1.9–2.4) | 2.0 (1.6–2.3) |
| History of smoking, n(%) | 2 (25%) | 2 (22.2%) | 2 (22.2%) |
| History of substance abuse | |||
| Ethyl alcohol abuse, n(%) | 2 (25%) | 2 (22.2%) | 2 (22.2%) |
| Drug abuse, n(%) | 2 (25%) | 2 (22.2%) | 2 (22.2%) |
| Vital signs | |||
| Systolic blood pressure (mmHg), mean±SD | 95.7±20.0 | 100.4±12.1 | 98.5±22.7 |
| Diastolic blood pressure (mmHg), mean±SD | 56.3±8.8 | 58.6±7.2 | 69.0±25.3 |
| Past medical history | |||
| Heart failure, n(%) | 8 (100%) | 9 (100%) | 9 (100%) |
| Diabetes mellitus, n(%) | 2 (25%) | 3 (33.3%) | 3 (33.3%) |
| Hypertension, n(%) | 4 (50%) | 5 (55.6%) | 4 (44.4%) |
| Etiology of heart disease | |||
| Ischemic cardiomyopathy, n(%) | 3 (37.5%) | 5 (55.6%) | 1 (11.1%) |
| Non-ischemic cardiomyopathy, n(%) | 5 (62.5%) | 3 (33.3%) | 5 (55.6%) |
| Idiopathic Cardiomyopathy, n(%) | - | 1 (11.1%) | 3 (33.3%) |
| Echocardiographic parameters | |||
| Left ventricular end diastolic diameter (mm), mean±SD | 71.4±11.0 | 61.4±9.2 | 77.7±10.5 |
| Left ventricular ejection fraction, (%), mean±SD | 12.5±4.2 | 15.0±3.2 | 12.5±5.0 |